MKS Instruments Inc.: 10-K Risk Factor Changes

2026 vs 2025  ·  SEC EDGAR  ·  2026-06-01
Other years: 2025 vs 2024 · 2024 vs 2023
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

71
New Risks
2
Removed
16
Modified
13
Unchanged
🟢 New in Current Filing

Emerging issues related to the development, deployment, and use of AI, including generative AI, in our business could give rise to competitive disadvantages, reputational harm, legal or regulatory action, or other adverse impacts on our business.

We are in the early stages of integrating AI into our business and operational processes and continue to explore new uses. AI technologies are complex and rapidly evolving. They may be difficult and costly to implement and govern, with no assurance that our investments in AI…

Read full text

We are in the early stages of integrating AI into our business and operational processes and continue to explore new uses. AI technologies are complex and rapidly evolving. They may be difficult and costly to implement and govern, with no assurance that our investments in AI will deliver anticipated benefits. Our competitors may adopt or leverage AI more quickly or effectively, achieving greater benefits, which could potentially diminish our market position. AI tools can produce outputs that are erroneous, misleading, biased, or otherwise flawed due to inaccurate, incomplete, or skewed training data, algorithms, or methodologies. Reliance on AI outputs without adequate human oversight and control mechanisms may lead to operational inefficiencies or disruptions, poor business decisions or reputational damage. Our use of AI raises significant IP, data protection and privacy, cybersecurity, and ethical considerations. Improper development, deployment or use of AI tools by our employees or business partners would increase the risk of loss of confidential or proprietary information, complicate assertion or enforcement of IP rights, introduce defects or malware into our products or business systems, or expose us to claims of infringement, misappropriation, or other violations of third-party rights, including individual rights such as privacy rights. Reliance on third-party vendors that use AI may introduce additional implementation, security, and compliance risks. The legal and regulatory landscape governing AI is dynamic, with evolving frameworks addressing data protection and privacy, IP, and responsible AI practices. Compliance may be costly and require significant resources and could restrict certain AI applications or limit our ability to deploy AI capabilities. Failure to anticipate, implement, and maintain appropriate governance and risk management controls, or to comply with applicable laws and standards, could result in sensitive data loss, regulatory scrutiny, legal liability, increased costs, or reputational damage.

🟢 New in Current Filing We are obligated to develop and maintain proper and effective internal control over financial reporting, and we previously identified a material weakness in our internal control over financial reporting and may discover additional material weaknesses 🔒
🟢 New in Current Filing Some provisions of our Restated Articles of Organization, our Second Amended and Restated By-laws, as amended, and Massachusetts law could discourage potential acquisition proposals and could delay, deter or prevent a change in control. 🔒
🟢 New in Current Filing Risk Management and Strategy 🔒
🟢 New in Current Filing Common Stock 🔒
🟢 New in Current Filing Dividend Policy and Cash Dividends 🔒
🟢 New in Current Filing Share Repurchase Program 🔒
🟢 New in Current Filing Comparative Stock Performance 🔒
🟢 New in Current Filing Performance Graph 🔒
🟢 New in Current Filing Current Trade Environment 🔒
🟢 New in Current Filing Semiconductor Market 🔒
🟢 New in Current Filing Electronics and Packaging Market 🔒
🟢 New in Current Filing Specialty Industrial Market 🔒
🟢 New in Current Filing International Markets 🔒
🟢 New in Current Filing Critical Accounting Policies and Estimates 🔒
🟢 New in Current Filing Results of Operations 🔒
🟢 New in Current Filing Year Ended December 31, 2025 compared to 2024 🔒
🟢 New in Current Filing Liquidity and Capital Resources 🔒
🟢 New in Current Filing Contractual Obligations 🔒
🟢 New in Current Filing Recent Accounting Pronouncements 🔒
🟢 New in Current Filing Market Risk and Sensitivity Analysis 🔒
🟢 New in Current Filing Foreign Exchange Rate Risk 🔒
🟢 New in Current Filing Interest Rate Risk 🔒
🟢 New in Current Filing Equity Price Risk 🔒
🟢 New in Current Filing Report of Independent Registered Public Accounting Firm 🔒
🟢 New in Current Filing Opinions on the Financial Statements and Internal Control over Financial Reporting 🔒
🟢 New in Current Filing Basis for Opinions 🔒
🟢 New in Current Filing Definition and Limitations of Internal Control over Financial Reporting 🔒
🟢 New in Current Filing Critical Audit Matters 🔒
🟢 New in Current Filing (in millions, except per share data) 🔒
🟢 New in Current Filing LIABILITIES AND STOCKHOLDERS’ EQUITY 🔒
🟢 New in Current Filing (in millions, except per share data) 🔒
🟢 New in Current Filing (in millions, except per share data) 🔒
🟢 New in Current Filing (in millions) 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Business Description 🔒
🟢 New in Current Filing Basis of Presentation 🔒
🟢 New in Current Filing Summary of Significant Accounting Policies 🔒
🟢 New in Current Filing Revenue from Contracts with Customers 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Accounts Receivable Allowances 🔒
🟢 New in Current Filing Research and Development 🔒
🟢 New in Current Filing Advertising Costs 🔒
🟢 New in Current Filing Government Incentives 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Stock-Based Compensation 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Accumulated Other Comprehensive Income (Loss) 🔒
🟢 New in Current Filing Net Income (Loss) Per Share 🔒
🟢 New in Current Filing Cash and Cash Equivalents and Investments 🔒
🟢 New in Current Filing Concentrations of Credit Risk 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Inventories 🔒
🟢 New in Current Filing Property, Plant and Equipment 🔒
🟢 New in Current Filing Acquisition Accounting 🔒
🟢 New in Current Filing Intangible Assets 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Long-Lived Assets 🔒
🟢 New in Current Filing Foreign Exchange 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Employee Benefit Plans 🔒
🟢 New in Current Filing Income Taxes 🔒
🟢 New in Current Filing Derivatives 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Recent Accounting Pronouncements 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Revenue from Contracts with Customers 🔒
🟢 New in Current Filing NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 🔒
🟢 New in Current Filing Net Income (Loss) Per Share 🔒
🟢 New in Current Filing Fair Value Measurements 🔒
🔴 No Match in Current Filing As part of our business strategy, we have consummated and may continue to pursue business combinations and acquisitions that may be difficult to identify and complete, challenging and costly to integrate, disruptive to our business and our management, and/or dilutive to stockholder value. 🔒
🔴 No Match in Current Filing Some provisions of our Restated Articles of Organization, as amended, our Second Amended and Restated By-laws and Massachusetts law could discourage potential acquisition proposals and could delay or prevent a change in control. 🔒
🟡 Modified The terms of our Term Loan Facility, Revolving Facility and 2034 Notes impose significant financial obligations and risks upon us, limit our ability to take certain actions, and could discourage a change in control. 🔒
🟡 Modified We are subject to international trade compliance regulations, and violations of those regulations could result in fines or trade restrictions, which could have a material adverse effect on us. 🔒
🟡 Modified A material amount of our assets represents goodwill and intangible assets, against which we have recorded impairments in the past, and our net income may be significantly reduced by future impairments of these assets. 🔒
🟡 Modified The loss of net revenues from any of our major customers would likely have a material adverse effect on us. 🔒
🟡 Modified Our failure to successfully manage the transition of certain of our products to other manufacturing locations, the transition of certain of our products to or from contract manufacturers, and the transition of certain functions to centralized locations would likely harm our business, financial condition and operating results. 🔒
🟡 Modified We are exposed to various risks related to legal proceedings, including, for example, product liability claims, intellectual property infringement claims, regulatory claims, contractual claims and class action litigation, which if successful, could have a material adverse effect on our commercial relationships, business, financial condition and operating results. 🔒
🟡 Modified The market price of our common stock has fluctuated and may continue to fluctuate for reasons over which we have no control. 🔒
🟡 Modified We are exposed to risks related to cybersecurity and data privacy threats and incidents, such as the ransomware event we identified in February 2023, and we are subject to restrictions and changes in laws and regulations governing data privacy and data protection, any of which could have a material adverse effect on our business. 🔒
🟡 Modified We face significant risks associated with doing business internationally. 🔒
🟡 Modified If significant trade restrictions or tariffs on our products or components that are imported from or exported to certain countries, including, but not limited to, China, are initiated, continue or are expanded, our business, financial condition and operating results may be materially harmed. 🔒
🟡 Modified Our substantial consolidated indebtedness could adversely affect us, including by increasing our interest expense and decreasing our business flexibility. 🔒
🟡 Modified Our proprietary technology is important to the continued success of our business. Our failure to protect this proprietary technology may significantly impair our competitive position. 🔒
🟡 Modified Supply chain disruptions and other manufacturing interruptions or delays have affected our ability to meet customer demand and have led to higher costs, while the failure to estimate customer demand accurately has resulted in excess or obsolete inventory, all of which has negatively impacted, and could in the future negatively impact, our business. 🔒
🟡 Modified Our products could contain defects, which would increase our costs and seriously harm our business, financial condition, operating results and customer relationships. 🔒
🟡 Modified The semiconductor, electronics manufacturing and automotive industries we serve are characterized by periodic fluctuations in business activity that may cause a reduction in demand for our products. 🔒
🟡 Modified Key personnel have been, and may continue to be, difficult to attract and retain. 🔒
88 more changes in this filing

Full diff access, historical comparisons, and cross-company signal tracking.

Get full access — from $29/month Already a Pro subscriber? View full diff →